Use of iPSCs in Alzheimer’s Disease Brain Inflammation
History of Alzheimer's Disease
More awareness is drawn to Alzheimer's. The National Alzheimer's Project Act is passed to further research and patient care.
The drug "Tacrine" becomes the first FDA-approved medication for Alzheimer's.
1904
2000s
2020-2023
1993
2010s
Alzheimer's Disease is first described by Dr. Alois Alzheimer.
Brain scans begin to be used to more thoroughly research Alzheimer's. More distinctions are drawn between Alzheimer's and similar diseases.
The drug "Lecanemab" is created and passed by the FDA to slow Alzheimer's progression.
Current Treatments for CBI
Donanemab and Lecanemab
-
Targets amyloid plaques
-
Requires regular MRI scans
-
Risk of Amyloid-Related Imaging Abnormalities (ARIAS,) which can cause visual disturbances, seizures, and even death
Neuromodulation
-
Still in the research and clinical trials stage and not on actual patients as of now